
GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO

Intrinsic Value
The intrinsic value of one
GLAXO
stock under the Base Case scenario is
1 283.4152
INR.
Compared to the current market price of 2 859.8999 INR,
GlaxoSmithKline Pharmaceuticals Ltd
is
Overvalued by 55%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
GlaxoSmithKline Pharmaceuticals Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
GlaxoSmithKline Pharmaceuticals Ltd
Balance Sheet Decomposition
GlaxoSmithKline Pharmaceuticals Ltd
Current Assets | 30.1B |
Cash & Short-Term Investments | 21.9B |
Receivables | 2.7B |
Other Current Assets | 5.6B |
Non-Current Assets | 7.3B |
Long-Term Investments | 118.5m |
PP&E | 3B |
Intangibles | 183.4m |
Other Non-Current Assets | 4B |
Free Cash Flow Analysis
GlaxoSmithKline Pharmaceuticals Ltd
INR | |
Free Cash Flow | INR |
Earnings Waterfall
GlaxoSmithKline Pharmaceuticals Ltd
Revenue
|
37B
INR
|
Cost of Revenue
|
-14.1B
INR
|
Gross Profit
|
23B
INR
|
Operating Expenses
|
-12.7B
INR
|
Operating Income
|
10.3B
INR
|
Other Expenses
|
-1.7B
INR
|
Net Income
|
8.6B
INR
|
GLAXO Profitability Score
Profitability Due Diligence
GlaxoSmithKline Pharmaceuticals Ltd's profitability score is 81/100. The higher the profitability score, the more profitable the company is.

Score
GlaxoSmithKline Pharmaceuticals Ltd's profitability score is 81/100. The higher the profitability score, the more profitable the company is.
GLAXO Solvency Score
Solvency Due Diligence
GlaxoSmithKline Pharmaceuticals Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Score
GlaxoSmithKline Pharmaceuticals Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GLAXO Price Targets Summary
GlaxoSmithKline Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for
GLAXO
is 2 670.105 INR
with a low forecast of 2 191.7 INR and a high forecast of 3 412.5 INR.
Dividends
Current shareholder yield for GLAXO is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
GLAXO
stock under the Base Case scenario is
1 283.4152
INR.
Compared to the current market price of 2 859.8999 INR,
GlaxoSmithKline Pharmaceuticals Ltd
is
Overvalued by 55%.